Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitlePhase-II-Studie zu Pembrolizumab (MK-3475) bei Patienten mit metastasiertem kastrationsresistenten Prostatakarzinom (KEYNOTE-199) – Studie AP 93/16 der AUO.AuthorsRexer, H.; Graefen, M.; Merseburger, A.; AUOPublicationDer Urologe A, 2017, Vol 56, Issue 11, p1471ISSN0340-2592Publication typeletterDOI10.1007/s00120-017-0519-9